37.300
+14,77%
2026-10-16
Fundamental Analysis
43 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +112.5% | +15.8% | 2 / 3 | +19.4% | -7.31 pp | +0.89 pp | +5.4% | 1.38 | 56.02 | 4.110 | +19,4% | 70,0 | +148,7% | 56.02 | 27.62 | +102,8% |
| Pts | 12 | 0 | 8 | 8 | 0 | 8 | 0 | 6 | 4 | |||||||
Valuation annotation:Price: 37.300 (close price on 2026-10-16)EPS (TTM): 665,8
Financial charts
1.Revenue & growth
VND bn4.110Q2/26
1.Revenue & growth
VND bn4.110Q2/26
2.Profit & growth
VND bn68,5Q2/26
3.Profit mix (Penman)
VND bn333Q2/26
4.Margins & cost structure
%2.1%Q2/26
5.Returns & cash cycle
% · days-0.7%Q2/26
6.Earnings quality & cash
VND bn-1.764Q2/26
7.Asset structure
VND bn20.287Q2/26
8.Funding & debt health
VND bn · times20.287Q2/26
9.Revenue backlog
VND bn3.702Q2/26
10.Valuation
times · %73,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %172Q2/26
Adjusted EPS growth, latest quarter
154%
Average adjusted EPS growth, 3 quarters
22.2%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26